Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Review
  • Published:

Early neuropsychological detection of Alzheimer's disease

European Journal of Clinical Nutrition volume 68, pages 1192–1199 (2014)Cite this article

Subjects

Abstract

Lifestyle modification offers a promising way of preventing or delaying Alzheimer’s disease (AD). In particular, nutritional interventions can contribute to decrease the risk of dementia. The efficacy of such interventions should be assessed in individuals thought to be prone to AD. It is therefore necessary to identify markers that may help detecting AD as early as possible. This review will focus on subtle neuropsychological changes that may already exist in the predementia phase, and that could point to individuals at risk of dementia. Episodic memory decline appears consistently as the earliest sign of incipient typical AD. An episodic memory test that ensures deep encoding of information and assesses retrieval with free as well as cued recall appears as a useful tool to detect patients at an early stage of AD. Beyond the memory domain, category verbal fluency has been shown to decline early and to predict progression to AD. Moreover, in line with current diagnosis criteria for prodromal AD, combining neuropsychological scores and neuroimaging data allows a better discrimination of future AD patients than neuroimaging or neuropsychological data alone. Altogether, the detection of cognitive changes that are predictive of the typical form of probable AD already in the predementia stage points to at risk people who are the best target for therapeutic interventions, such as nutrition or physical exercise counseling or dietary interventions.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1

Similar content being viewed by others

References

  1. McKhann GM, Knopman DS, Chertkow H, Hyman BT, Jack Jr CR Kawas CH et al. The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 2011; 7: 263–269.

    PubMed  PubMed Central  Google Scholar 

  2. Jack Jr CR Holtzman DM . Biomarker modeling of Alzheimer's disease. Neuron 2013; 80: 1347–1358.

    CAS  PubMed  PubMed Central  Google Scholar 

  3. Villemagne VL, Burnham S, Bourgeat P, Brown B, Ellis KA, Salvado O et al. Amyloid beta deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: a prospective cohort study. Lancet Neurol 2013; 12: 357–367.

    CAS  PubMed  Google Scholar 

  4. Reiman EM, Langbaum JB, Fleisher AS, Caselli RJ, Chen K, Ayutyanont N et al. Alzheimer's Prevention Initiative: a plan to accelerate the evaluation of presymptomatic treatments. J Alzheimers Dis 2011; 26 (Suppl 3): 321–329.

    PubMed  PubMed Central  Google Scholar 

  5. Stern Y . Cognitive reserve in ageing and Alzheimer's disease. Lancet Neurol 2012; 11: 1006–1012.

    PubMed  PubMed Central  Google Scholar 

  6. Nourhashemi F, Gillette-Guyonnet S, Andrieu S, Ghisolfi A, Ousset PJ, Grandjean H et al. Alzheimer disease: protective factors. Am J Clin Nutr 2000; 71: 643s–649s.

    CAS  PubMed  Google Scholar 

  7. Helmer C, Peuchant E, Letenneur L, Bourdel-Marchasson I, Larrieu S, Dartigues JF et al. Association between antioxidant nutritional indicators and the incidence of dementia: results from the PAQUID prospective cohort study. Eur J Clin Nutr 2003; 57: 1555–1561.

    CAS  PubMed  Google Scholar 

  8. Ronnemaa E, Zethelius B, Vessby B, Lannfelt L, Byberg L, Kilander L . Serum fatty-acid composition and the risk of Alzheimer's disease: a longitudinal population-based study. Eur J Clin Nutr 2012; 66: 885–890.

    CAS  PubMed  Google Scholar 

  9. Bandayrel K, Wong S . Systematic literature review of randomized control trials assessing the effectiveness of nutrition interventions in community-dwelling older adults. J Nutr Educ Behav 2011; 43: 251–262.

    PubMed  Google Scholar 

  10. Barberger-Gateau P, Samieri C, Allès B, Féart C . Could nutrition prevent the onset of dementia? Current evidence from epidemiological and intervention studies. Future Medicine 2012; 2: 305–314.

    Google Scholar 

  11. Shah R . The role of nutrition and diet in Alzheimer disease: a systematic review. J Am Med Dir Assoc 2013; 14: 398–402.

    PubMed  Google Scholar 

  12. Masur DM, Sliwinski M, Lipton RB, Blau AD, Crystal HA . Neuropsychological prediction of dementia and the absence of dementia in healthy elderly persons. Neurology 1994; 44: 1427.

    CAS  PubMed  Google Scholar 

  13. Elias MF, Beiser A, Wolf PA, Au R, White RF, D'Agostino RB . The preclinical phase of alzheimer disease: A 22-year prospective study of the Framingham Cohort. Arch Neurol 2000; 57: 808–813.

    CAS  PubMed  Google Scholar 

  14. Saxton J, Lopez OL, Ratcliff G, Dulberg C, Fried LP, Carlson MC et al. Preclinical Alzheimer disease: neuropsychological test performance 1.5 to 8 years prior to onset. Neurology 2004; 63: 2341–2347.

    CAS  PubMed  Google Scholar 

  15. Tierney MC, Yao C, Kiss A, McDowell I . Neuropsychological tests accurately predict incident Alzheimer disease after 5 and 10 years. Neurology 2005; 64: 1853–1859.

    PubMed  Google Scholar 

  16. Hall CB, Ying J, Kuo L, Sliwinski M, Buschke H, Katz M et al. Estimation of bivariate measurements having different change points, with application to cognitive ageing. Stat Med 2001; 20: 3695–3714.

    CAS  PubMed  Google Scholar 

  17. Grober E, Hall CB, Lipton RB, Zonderman AB, Resnick SM, Kawas C . Memory impairment, executive dysfunction, and intellectual decline in preclinical Alzheimer's disease. J Int Neuropsychol Soc 2008; 14: 266–278.

    PubMed  PubMed Central  Google Scholar 

  18. Wilson RS, Leurgans SE, Boyle PA, Bennett DA . Cognitive decline in prodromal Alzheimer disease and mild cognitive impairment. Arch Neurol 2011; 68: 351–356.

    PubMed  PubMed Central  Google Scholar 

  19. Petersen RC, Smith GE, Waring SC, Ivnik RJ, Tangalos EG, Kokmen E . Mild cognitive impairment: Clinical characterization and outcome. Arch Neurol 1999; 56: 303–308.

    CAS  PubMed  Google Scholar 

  20. Petersen RC, Negash S . Mild cognitive impairment: An overview. CNS Spectr 2008; 13: 45–53.

    PubMed  Google Scholar 

  21. Mitchell AJ, Shiri-Feshki M . Rate of progression of mild cognitive impairment to dementia–meta-analysis of 41 robust inception cohort studies. Acta Psychiatr Scand 2009; 119: 252–265.

    CAS  PubMed  Google Scholar 

  22. Caselli RJ, Locke DE, Dueck AC, Knopman DS, Woodruff BK, Hoffman-Snyder C et al. The neuropsychology of normal aging and preclinical Alzheimer's disease. Alzheimers Dement 2014; 10: 84–92.

    PubMed  Google Scholar 

  23. Tierney MC, Szalai JP, Snow WG, Fisher RH, Nores A, Nadon G et al. Prediction of probable Alzheimer's disease in memory-impaired patients: A prospective longitudinal study. Neurology 1996; 46: 661–665.

    CAS  PubMed  Google Scholar 

  24. Fowler KS, Saling MM, Conway EL, Semple JM, Louis WJ . Paired associate performance in the early detection of DAT. J Int Neuropsychol Soc 2002; 8: 58–71.

    PubMed  Google Scholar 

  25. Artero S, Tierney MC, Touchon J, Ritchie K . Prediction of transition from cognitive impairment to senile dementia: a prospective, longitudinal study. Acta Psychiatr Scand 2003; 107: 390–393.

    CAS  PubMed  Google Scholar 

  26. Blackwell AD, Sahakian BJ, Vesey R, Semple JM, Robbins TW, Hodges JR . Detecting dementia: novel neuropsychological markers of preclinical Alzheimer's disease. Dement Geriatr Cogn Disord 2004; 17: 42–48.

    PubMed  Google Scholar 

  27. Ivanoiu A, Adam S, Van der Linden M, Salmon E, Juillerat AC, Mulligan R et al. Memory evaluation with a new cued recall tests in patients with mild cognitive impairment and Alzheimer's disease. J Neurol 2005; 252: 47–55.

    PubMed  Google Scholar 

  28. Tabert MH, Manly JJ, Liu X, Pelton GH, Rosenblum S, Jacobs M et al. Neuropsychological prediction of conversion to Alzheimer disease in patients with mild cognitive impairment. Arch Gen Psychiatry 2006; 63: 916–924.

    PubMed  Google Scholar 

  29. Griffith HR, Netson KL, Harrell LE, Zamrini EY, Brockington JC, Marson DC . Amnestic mild cognitive impairment: diagnostic outcomes and clinical prediction over a two-year time period. J Int Neuropsychol Soc 2006; 12: 166–175.

    PubMed  Google Scholar 

  30. Marcos A, Gil P, Barabash A, Rodriguez R, Encinas M, Fernandez C et al. Neuropsychological markers of progression from mild cognitive impairment to Alzheimer's disease. Am J Alzheimers Dis Other Demen 2006; 21: 189–196.

    PubMed  Google Scholar 

  31. Hodges JR, Erzinçlioglu S, Patterson K . Evolution of cognitive deficits and conversion to dementia in patients with mild cognitive impairment: A very-long term follow-up study. Dement Geriatr Cogn Disord 2006; 21: 380–391.

    PubMed  Google Scholar 

  32. Albert M, Blacker D, Moss MB, Tanzi R, McArdle JJ . Longitudinal change in cognitive performance among individuals with mild cognitive impairment. Neuropsychology 2007; 21: 158–169.

    PubMed  Google Scholar 

  33. Blacker D, Lee H, Muzikansky A, Martin EC, Tanzi R, McArdle JJ et al. Neuropsychological measures in normal individuals that predict subsequent cognitive decline. Arch Neurol 2007; 64: 862–871.

    PubMed  Google Scholar 

  34. Fleisher AS, Sowell BB, Taylor C, Gamst AC, Petersen RC, Thal LJ . Clinical predictors of progression to Alzheimer disease in amnestic mild cognitive impairment. Neurology 2007; 68: 1588–1595.

    CAS  PubMed  Google Scholar 

  35. Rami L, Gomez-Anson B, Sanchez-Valle R, Bosch B, Monte GC, Llado A et al. Longitudinal study of amnesic patients at high risk for Alzheimer's disease: clinical, neuropsychological and magnetic resonance spectroscopy features. Dement Geriatr Cogn Disord 2007; 24: 402–410.

    PubMed  Google Scholar 

  36. Perri R, Serra L, Carlesimo GA, Caltagirone C . Early Diagnosis Group of the Italian Interdisciplinary Network on Alzheimer's D. Amnestic mild cognitive impairment: difference of memory profile in subjects who converted or did not convert to Alzheimer's disease. Neuropsychology 2007; 21: 549–558.

    PubMed  Google Scholar 

  37. Sarazin M, Berr C, De Rotrou J, Fabrigoule C, Pasquier F, Legrain S et al. Amnestic syndrome of the medial temporal type identifies prodromal AD: a longitudinal study. Neurology 2007; 69: 1859–1867.

    CAS  PubMed  Google Scholar 

  38. Ahmed S, Mitchell J, Arnold R, Nestor PJ, Hodges JR . Predicting rapid clinical progression in amnestic mild cognitive impairment. Dement Geriatr Cogn Disord 2008; 25: 170–177.

    PubMed  Google Scholar 

  39. Rabin LA, Pare N, Saykin AJ, Brown MJ, Wishart HA, Flashman LA et al. Differential memory test sensitivity for diagnosing amnestic mild cognitive impairment and predicting conversion to Alzheimer's disease. Neuropsychol Dev Cogn B Aging Neuropsychol Cogn 2009; 16: 357–376.

    PubMed  PubMed Central  Google Scholar 

  40. Lekeu F, Magis D, Marique P, Delbeuck X, Bechet S, Guillaume B et al. The California Verbal Learning Test and other standard clinical neuropsychological tests to predict conversion from mild memory impairment to dementia. J Clin Exp Neuropsychol 2010; 32: 164–173.

    PubMed  Google Scholar 

  41. Pozueta A, Rodriguez-Rodriguez E, Vazquez-Higuera JL, Mateo I, Sanchez-Juan P, Gonzalez-Perez S et al. Detection of early Alzheimer's disease in MCI patients by the combination of MMSE and an episodic memory test. BMC Neurol 2011; 11: 78.

    PubMed  PubMed Central  Google Scholar 

  42. Hanseeuw B, Ivanoiu A . Performance on the RI-48 cued recall test best predicts conversion to dementia at the 5- and 10-year follow-ups. Dement Geriatr Cogn Dis Extra 2011; 1: 258–266.

    PubMed  PubMed Central  Google Scholar 

  43. Molinuevo JL, Gomez-Anson B, Monte GC, Bosch B, Sanchez-Valle R, Rami L . Neuropsychological profile of prodromal Alzheimer's disease (Prd-AD) and their radiological correlates. Arch Gerontol Geriatr 2011; 52: 190–196.

    PubMed  Google Scholar 

  44. Irish M, Lawlor BA, Coen RF, O'Mara SM . Everyday episodic memory in amnestic mild cognitive impairment: a preliminary investigation. BMC Neurosci 2011; 12: 80.

    PubMed  PubMed Central  Google Scholar 

  45. Gomez-Tortosa E, Mahillo-Fernandez I, Guerrero R, Montoya J, Alonso A, Sainz MJ . Outcome of mild cognitive impairment comparing early memory profiles. Am J Geriatr Psychiatry 2012; 20: 827–835.

    PubMed  Google Scholar 

  46. Cunha C, Guerreiro M, de Mendonca A, Oliveira PE, Santana I . Serial position effects in Alzheimer's disease, mild cognitive impairment, and normal aging: predictive value for conversion to dementia. J Clin Exp Neuropsychol 2012; 34: 841–852.

    PubMed  Google Scholar 

  47. Schmand B, Eikelenboom P, van Gool WA . Value of diagnostic tests to predict conversion to Alzheimer's disease in young and old patients with amnestic mild cognitive impairment. J Alzheimers Dis 2012; 29: 641–648.

    PubMed  Google Scholar 

  48. Didic M, Felician O, Barbeau EJ, Mancini J, Latger-Florence C, Tramoni E et al. Impaired visual recognition memory predicts Alzheimer's disease in amnestic mild cognitive impairment. Dement Geriatr Cogn Disord 2013; 35: 291–299.

    PubMed  Google Scholar 

  49. Mura T, Proust-Lima C, Jacqmin-Gadda H, Akbaraly TN, Touchon J, Dubois B et al. Measuring cognitive change in subjects with prodromal Alzheimer's disease. J Neurol Neurosurg Psychiatry 2013; 85: 363–370.

    PubMed  Google Scholar 

  50. Paajanen T, Hanninen T, Tunnard C, Hallikainen M, Mecocci P, Sobow T et al. CERAD neuropsychological compound scores are accurate in detecting prodromal alzheimer's disease: a prospective addneuromed study. J Alzheimers Dis 2014; 39: 679–690.

    PubMed  Google Scholar 

  51. Lyness SA, Lee AY, Zarow C, Teng EL, Chui HC . 10-minute delayed recall from the modified mini-mental state test predicts Alzheimer's disease pathology. J Alzheimers Dis 2014; 39: 575–582.

    PubMed  PubMed Central  Google Scholar 

  52. Amieva H, Jacqmin-Gadda H, Orgogozo JM, Le Carret N, Helmer C, Letenneur L et al. The 9 year cognitive decline before dementia of the Alzheimer type: A prospective population-based study. Brain 2005; 128: 1093–1101.

    PubMed  Google Scholar 

  53. Smith GE, Pankratz VS, Negash S, Machulda MM, Petersen RC, Boeve BF et al. A plateau in pre-Alzheimer memory decline: evidence for compensatory mechanisms? Neurology 2007; 69: 133–139.

    CAS  PubMed  Google Scholar 

  54. Howieson DB, Dame A, Camicioli R, Sexton G, Payami H, Kaye JA . Cognitive markers preceding Alzheimer's dementia in the healthy oldest old. J Am Geriatr Soc 1997; 45: 584–589.

    CAS  PubMed  Google Scholar 

  55. Small BJ, Fratiglioni L, Viitanen M, Winblad B, Backman L . The course of cognitive impairment in preclinical Alzheimer disease: three- and 6-year follow-up of a population-based sample. Arch Neurol 2000; 57: 839–844.

    CAS  PubMed  Google Scholar 

  56. Chen P, Ratcliff G, Belle SH, Cauley JA, DeKosky ST, Ganguli M . Cognitive tests that best discriminate between presymptomatic AD and those who remain nondemented. Neurology 2000; 55: 1847–1853.

    CAS  PubMed  Google Scholar 

  57. Schmid NS, Taylor KI, Foldi NS, Berres M, Monsch AU . Neuropsychological signs of Alzheimer's disease 8 years prior to diagnosis. J Alzheimers Dis 2013; 34: 537–546.

    CAS  PubMed  Google Scholar 

  58. Buschke H, Sliwinski MJ, Kuslansky G, Lipton RB . Diagnosis of early dementia by the Double Memory Test: encoding specificity improves diagnostic sensitivity and specificity. Neurology 1997; 48: 989–997.

    CAS  PubMed  Google Scholar 

  59. Adam S, Van der Linden M, Poitrenaud J, Kalafat M . GREMEM lmd. L'épreuve de rappel indicé à 48 items (RI-48). In: Van der Linden M editor. L'évaluation des troubles de la mémoire: Présentation de quatre tests de mémoire épisodique (avec leur étalonnage). Marseille: Solal, 2004.

    Google Scholar 

  60. Grober E, Buschke H, Crystal H, Bang S, Dresner R . Screening for dementia by memory testing. Neurology 1988; 38: 900–903.

    CAS  PubMed  Google Scholar 

  61. Grober E, Lipton RB, Hall C, Crystal H . Memory impairment on free and cued selective reminding predicts dementia. Neurology 2000; 54: 827–832.

    CAS  PubMed  Google Scholar 

  62. Carlesimo GA, Perri R, Caltagirone C . Category cued recall following controlled encoding as a neuropsychological tool in the diagnosis of Alzheimer's disease: a review of the evidence. Neuropsychol Rev 2011; 21: 54–65.

    PubMed  Google Scholar 

  63. Dubois B, Feldman HH, Jacova C, DeKosky ST, Barberger-Gateau P, Cummings J et al. Research criteria for the diagnosis of Alzheimer's disease: Revising the NINCDS-ADRDA criteria. Lancet Neurol 2007; 6: 734–746.

    PubMed  Google Scholar 

  64. Braak H, Braak E . Neuropathological stageing of Alzheimer-related changes. Acta Neuropathologica 1991; 82: 239–259.

    CAS  PubMed  Google Scholar 

  65. Lekeu F, Van der Linden M, Chicherio C, Collette F, Degueldre C, Franck G et al. Brain correlates of performance in a free/cued recall task with semantic encoding in Alzheimer disease. Alzheimer Dis Assoc Disord 2003; 17: 35–45.

    PubMed  Google Scholar 

  66. Sarazin M, Chauvire V, Gerardin E, Colliot O, Kinkingnehun S, de Souza LC et al. The amnestic syndrome of hippocampal type in Alzheimer's disease: an MRI study. J Alzheimers Dis 2010; 22: 285–294.

    PubMed  Google Scholar 

  67. Davachi L . Item, context and relational episodic encoding in humans. Curr Opin Neurobiol 2006; 16: 693–700.

    CAS  PubMed  Google Scholar 

  68. Gainotti G, Quaranta D, Vita MG, Marra C . Neuropsychological predictors of conversion from mild cognitive impairment to Alzheimer's disease. J Alzheimers Dis 2014; 38: 481–495.

    CAS  PubMed  Google Scholar 

  69. Bruscoli M, Lovestone S . Is MCI really just early dementia? A systematic review of conversion studies. Int Psychogeriatr 2004; 16: 129–140.

    PubMed  Google Scholar 

  70. Amieva H, Le Goff M, Millet X, Orgogozo JM, Peres K, Barberger-Gateau P et al. Prodromal Alzheimer's disease: successive emergence of the clinical symptoms. Ann Neurol 2008; 64: 492–498.

    PubMed  Google Scholar 

  71. Riley KP, Jicha GA, Davis D, Abner EL, Cooper GE, Stiles N et al. Prediction of preclinical Alzheimer's disease: longitudinal rates of change in cognition. J Alzheimers Dis 2011; 25: 707–717.

    PubMed  PubMed Central  Google Scholar 

  72. Small BJ, Herlitz A, Fratiglioni L, Almkvist O, Backman L . Cognitive predictors of incident Alzheimer's disease: a prospective longitudinal study. Neuropsychology 1997; 11: 413–420.

    CAS  PubMed  Google Scholar 

  73. Raoux N, Amieva H, Le Goff M, Auriacombe S, Carcaillon L, Letenneur L et al. Clustering and switching processes in semantic verbal fluency in the course of Alzheimer's disease subjects: Results from the PAQUID longitudinal study. Cortex 2008; 44: 1188–1196.

    PubMed  Google Scholar 

  74. Barbeau EJ, Didic M, Joubert S, Guedj E, Koric L, Felician O et al. Extent and neural basis of semantic memory impairment in mild cognitive impairment. J Alzheimers Dis 2012; 28: 823–837.

    CAS  PubMed  Google Scholar 

  75. Arnaiz E, Jelic V, Almkvist O, Wahlund LO, Winblad B, Valind S et al. Impaired cerebral glucose metabolism and cognitive functioning predict deterioration in mild cognitive impairment. Neuroreport 2001; 12: 851–855.

    CAS  PubMed  Google Scholar 

  76. Jacobs DM, Sano M, Dooneief G, Marder K, Bell KL, Stern Y . Neuropsychological detection and characterization of preclinical Alzheimer's disease. Neurology 1995; 45: 957–962.

    CAS  PubMed  Google Scholar 

  77. Didic M, Ranjeva JP, Barbeau E, Confort-Gouny S, Fur YL, Felician O et al. Impaired visual recognition memory in amnestic mild cognitive impairment is associated with mesiotemporal metabolic changes on magnetic resonance spectroscopic imaging. J Alzheimers Dis 2010; 22: 1269–1279.

    CAS  PubMed  Google Scholar 

  78. De Anna F, Felician O, Barbeau E, Mancini J, Didic M, Ceccaldi M . Cognitive changes in mild cognitive impairment patients with impaired visual recognition memory. Neuropsychology 2014; 28: 98–105.

    PubMed  Google Scholar 

  79. Parra MA, Abrahams S, Fabi K, Logie R, Luzzi S, Della Sala S . Short-term memory binding deficits in Alzheimer's disease. Brain 2009; 132: 1057–1066.

    PubMed  Google Scholar 

  80. Della Sala S, Parra MA, Fabi K, Luzzi S, Abraham S . Short-term memory binding is impaired in AD but not in non-AD dementias. Neuropsychologia 2012; 50: 833–840.

    PubMed  Google Scholar 

  81. Parra MA . Cognitive assessement in Alzheimer's disease. Advances in Alzheimer's disease 2013; 2: 123–125.

    Google Scholar 

  82. Devanand DP, Liu X, Tabert MH, Pradhaban G, Cuasay K, Bell K et al. Combining early markers strongly predicts conversion from mild cognitive impairment to Alzheimer's disease. Biol Psychiatry 2008; 64: 871–879.

    PubMed  PubMed Central  Google Scholar 

  83. Albert MS, DeKosky ST, Dickson D, Dubois B, Feldman HH, Fox NC et al. The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 2011; 7: 270–279.

    PubMed  PubMed Central  Google Scholar 

  84. Sperling RA, Aisen PS, Beckett LA, Bennett DA, Craft S, Fagan AM et al. Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 2011; 7: 280–292.

    PubMed  PubMed Central  Google Scholar 

  85. Visser PJ, Scheltens P, Verhey FR, Schmand B, Launer LJ, Jolles J et al. Medial temporal lobe atrophy and memory dysfunction as predictors for dementia in subjects with mild cognitive impairment. J Neurol 1999; 246: 477–485.

    CAS  PubMed  Google Scholar 

  86. Peters F, Villeneuve S, Belleville S . Predicting progression to dementia in elderly subjects with mild cognitive impairment using both cognitive and neuroimaging predictors. J Alzheimers Dis 2014; 38: 307–318.

    PubMed  Google Scholar 

  87. Segovia F, Bastin C, Salmon E, Gorriz JM, Ramirez J, Phillips C . Combining PET images and neuropsychological test data for automatic diagnosis of Alzheimer's disease. PLoS One 2014; 9: e88687.

    PubMed  PubMed Central  Google Scholar 

  88. Linn RT, Wolf PA, Bachman DL, Knoefel JE, Cobb JL, Belanger AJ et al. The 'preclinical phase' of probable Alzheimer's disease. A 13-year prospective study of the Framingham cohort. Arch Neurol 1995; 52: 485–490.

    CAS  PubMed  Google Scholar 

  89. Chen P, Ratcliff G, Belle SH, Cauley JA, DeKosky ST, Ganguli M . Patterns of cognitive decline in presymptomatic Alzheimer disease: a prospective community study. Arch Gen Psychiatry 2001; 58: 853–858.

    CAS  PubMed  Google Scholar 

  90. Backman L, Small BJ, Fratiglioni L . Stability of the preclinical episodic memory deficit in Alzheimer's disease. Brain 2001; 124 (Pt 1): 96–102.

    CAS  PubMed  Google Scholar 

  91. Rapp MA, Reischies FM . Attention and executive control predict Alzheimer disease in late life: results from the Berlin Aging Study (BASE). Am J Geriatr Psychiatry 2005; 13: 134–141.

    PubMed  Google Scholar 

  92. Johnson DK, Storandt M, Morris JC, Galvin JE . Longitudinal study of the transition from healthy aging to Alzheimer disease. Arch Neurol 2009; 66: 1254–1259.

    PubMed  PubMed Central  Google Scholar 

  93. Auriacombe S, Helmer C, Amieva H, Berr C, Dubois B, Dartigues JF . Validity of the free and cued selective reminding test in predicting dementia: the 3C study. Neurology 2010; 74: 1760–1767.

    CAS  PubMed  Google Scholar 

  94. Rabin LA, Wang C, Katz MJ, Derby CA, Buschke H, Lipton RB . Predicting Alzheimer's disease: neuropsychological tests, self-reports, and informant reports of cognitive difficulties. J Am Geriatr Soc 2012; 60: 1128–1134.

    PubMed  PubMed Central  Google Scholar 

  95. Borroni B, Anchisi D, Paghera B, Vicini B, Kerrouche N, Garibotto V et al. Combined 99mTc-ECD SPECT and neuropsychological studies in MCI for the assessment of conversion to AD. Neurobiol Aging 2006; 27: 24–31.

    CAS  PubMed  Google Scholar 

  96. Gomar JJ, Bobes-Bascaran MT, Conejero-Goldberg C, Davies P, Goldberg TE . Utility of combinations of biomarkers, cognitive markers, and risk factors to predict conversion from mild cognitive impairment to Alzheimer disease in patients in the Alzheimer's disease neuroimaging initiative. Arch Gen Psychiatry 2011; 68: 961–969.

    PubMed  Google Scholar 

  97. Venneri A, Gorgoglione G, Toraci C, Nocetti L, Panzetti P, Nichelli P . Combining neuropsychological and structural neuroimaging indicators of conversion to Alzheimer's disease in amnestic mild cognitive impairment. Curr Alzheimer Res 2011; 8: 789–797.

    CAS  PubMed  Google Scholar 

Download references

Acknowledgements

CB is a Research Associate at the F.R.S-FNRS. Research conducted at the Cyclotron Research Centre is supported by ULg, FRS-FNRS, IUAP 7/11, ARC n° 12/17-01 REST, and SAO/FRA.

Author information

Authors and Affiliations

  1. Cyclotron Research Center, University of Liège, Liège, Belgium

    C Bastin & E Salmon

  2. Fund for Scientific Research, F.R.S.-FNRS, Brussels, Belgium

    C Bastin

  3. Memory Clinic, CHU Liège, Belgium

    E Salmon

Authors
  1. C Bastin
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. E Salmon
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to C Bastin.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Bastin, C., Salmon, E. Early neuropsychological detection of Alzheimer's disease. Eur J Clin Nutr 68, 1192–1199 (2014). https://doi.org/10.1038/ejcn.2014.176

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ejcn.2014.176

This article is cited by

Search

Advanced search

Quick links